XML 14 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2017
Mar. 31, 2016
ASSETS    
Cash and cash equivalents $ 8,664,211 $ 9,270,010
Accounts receivable, net of allowance for doubtful accounts of $475,080 and $601,000 at March 31, 2017 and 2016, respectively 5,506,472 3,392,941
Other receivables 464,085 581,213
Due from Affiliates 18,314 20,505
Prepaid expenses and other current assets 269,168 293,828
Total current assets 14,922,250 13,558,497
Deferred financing costs, net 0 37,926
Property and equipment, net 1,205,139 1,247,973
Restricted cash 765,058 530,000
Intangible assets, net 1,904,269 2,353,212
Goodwill 1,622,483 1,622,483
Other assets 225,358 216,442
TOTAL ASSETS 20,644,557 19,566,533
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY    
Accounts payable and accrued liabilities 7,883,373 4,572,307
Medical liabilities 1,768,231 2,670,709
Convertible note payable, net of debt issuance cost of $161,000 4,829,000 0
Lines of credit 62,500 188,764
Total current liabilities 14,543,104 7,431,780
Note payable - related party 5,000,000 0
Warrant liability 0 2,811,111
Deferred rent liability 747,418 728,877
Deferred tax liability 83,667 43,479
Total liabilities 20,374,189 11,015,247
COMMITMENTS AND CONTINGENCIES (Note 10)
STOCKHOLDERS’ EQUITY    
Common stock, par value $0.001; 100,000,000 shares authorized, 6,033,518 and 5,876,852 shares issued and outstanding at March 31, 2017 and 2016, respectively 6,033 5,876
Additional paid-in capital 26,331,948 23,524,517
Accumulated deficit (37,654,381) (28,684,565)
Stockholders’ deficit attributable to Apollo Medical Holdings, Inc. (353,877) (1,269,427)
Noncontrolling interest 624,245 2,742,935
Total stockholders’ equity 270,368 1,473,508
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY 20,644,557 19,566,533
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred Stock Value 7,077,778 0
Total stockholders’ equity 7,077,778 0
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred Stock Value 3,884,745 3,884,745
Total stockholders’ equity 3,884,745 3,884,745
MEZZANINE | Series A Preferred Stock [Member]    
MEZZANINE EQUITY    
Series A Preferred stock, par value $0.001; 5,000,000 shares authorized (inclusive of Series B Preferred stock); 1,111,111 issued and outstanding as of March 31, 2016, Liquidation preference of $9,999,999 at March 31, 2016 $ 0 $ 7,077,778